Drug development: A healthy pipeline

Branwen Morgan
Additional contact information
Branwen Morgan: Branwen Morgan is a freelance science writer based in Sydney, Australia.

Nature, 2016, vol. 533, issue 7603, S116-S117

Abstract: Drugs for irritable bowel syndrome have so far been limited, but a promising stream of options could soon enter the market.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/533S116a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:533:y:2016:i:7603:d:10.1038_533s116a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/533S116a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().